Wolverine Asset Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,177
Closed -$27.5K 1712
2023
Q4
$27.5K Sell
3,177
-671
-17% -$5.21K ﹤0.01% 1278
2023
Q3
$29.4K Sell
3,848
-484
-11% -$3.63K ﹤0.01% 1304
2023
Q2
$31.2K Hold
4,332
﹤0.01% 1229
2023
Q1
$26.4K Sell
4,332
-1,271
-23% -$6.89K ﹤0.01% 1298
2022
Q4
$24.4K Hold
5,603
﹤0.01% 1495
2022
Q3
$21K Hold
5,603
﹤0.01% 1818
2022
Q2
$28K Buy
5,603
+1,319
+31% +$6.86K ﹤0.01% 1745
2022
Q1
$27K Buy
4,284
+1,116
+35% +$7.4K ﹤0.01% 1701
2021
Q4
$25K Buy
3,168
+3,095
+4,240% +$29.2K ﹤0.01% 1662
2021
Q3
$0 Buy
+73
New +$763 ﹤0.01% 2037

Other funds holding CLBT

Wolverine Asset Management's CLBT Position: Q1 2024 in Review

Wolverine Asset Management sold out of Cellebrite (CLBT) in Q1 2024, closing a stake of 3,177 shares — an estimated $27.5K sold.

Wolverine Asset Management first reported a position in CLBT in Q3 2021 and held it in 10 quarters. The position peaked at $31.2K in Q2 2023. 141 funds tracked by Wall St. Rank hold CLBT as of Q1 2024.

  • Wolverine Asset Management reported no remaining Cellebrite position as of Q1 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 3,177 Cellebrite shares in Q1 2024, an estimated $27.5K.
  • Wolverine Asset Management first reported a position in Cellebrite in Q3 2021 and held it in 10 quarters.
  • Wolverine Asset Management's Cellebrite position peaked at $31.2K in Q2 2023.
  • 141 funds tracked by Wall St. Rank held Cellebrite as of Q1 2024.

Based on Wolverine Asset Management's 13F filing for Q1 2024, filed 13 May 2024.